SYNAIRGEN PLC

Major Shareholding Notification • Mar 27, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9245H

Synairgen plc

27 March 2020

Synairgen plc

("Synairgen" or the "Company")

Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 27 March 2020 that Leonard Licht, a private investor, now holds 9,720,000 ordinary shares of 1 pence each in the capital of the Company, representing 8.88% of the Company's issued share capital.

Enquiries:

Synairgen plc	+44 (0) 23 8051 2800
Richard Marsden (Chief Executive Officer) John Ward (Finance Director)
finnCap - nominated adviser and broker	+44 (0) 20 7220 0500
Geoff Nash / Kate Bannatyne / Charlie Beeson (Corporate Finance) Alice Lane / Manasa Patil (ECM)
Consilium Strategic Communications - financial media and investor relations adviser	+44 (0) 20 3709 5700
Mary-Jane Elliott / Sue Stuart / Olivia Manser

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLFLFLEVAIDFII